No Data
No Data
Novo Says Ozempic Succeeded in Late-stage Trial for Peripheral Artery Disease
Novo Nordisk Inks Licensing Pact With Lexicon for Obesity Candidate
Marty Makary and Jay Bhattacharya Clear Senate Hurdles to Lead FDA and NIH
Eli Lilly Launches Weight Loss Drug in India Beating Novo Nordisk
Novo Nordisk Rebounds as Kepler Upgrades Ozempic Maker at Long Last
Novo to Test If GLP-1 Weight Loss Drugs Can Help Curb Addiction